lo g2 c f t ite r dupilumab amphotericin ambisome fluconazole posaconazole immunomodulators antifungals (Gilead Sciences)
97
Structured Review
Gilead Sciences
lo g2 c f t ite r dupilumab amphotericin ambisome fluconazole posaconazole immunomodulators antifungals
Lo G2 C F T Ite R Dupilumab Amphotericin Ambisome Fluconazole Posaconazole Immunomodulators Antifungals, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 2955 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunomodulation/AmBisome/pm41778809-196-54-63
Average 97 stars, based on 2955 article reviews
Lo G2 C F T Ite R Dupilumab Amphotericin Ambisome Fluconazole Posaconazole Immunomodulators Antifungals, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 2955 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunomodulation/AmBisome/pm41778809-196-54-63
Average 97 stars, based on 2955 article reviews
lo g2 c f t ite r dupilumab amphotericin ambisome fluconazole posaconazole immunomodulators antifungals - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Recurrence of HIV-associated cryptococcal meningitis in pregnancy and the post-partum period. Article Snippet: We report a case of recurrent cryptococcal meningitis in a pregnant woman living with vertically acquired HIV.. Despite effective treatment of primary infection prior to pregnancy, she later experienced a microbiological relapse of cryptococcal meningitis during pregnancy, and an immune-reconstitution inflammatory syndrome in the post-partum period.. This case emphasises the impact of pregnancy related immunological changes on the natural history of complex infections. Article Title: Near-Full-Length Hepatitis B Virus Genomes Isolated from Cerebrospinal Fluid of People Living with HIV and Cryptococcal Meningitis in Botswana Article Snippet: .. This was a retrospective cross-sectional study utilizing archived baseline plasma and CSF samples collected from participants enrolled at the Botswana site for the Sterility:Article Title: Recurrence of HIV-associated cryptococcal meningitis in pregnancy and the post-partum period. Article Snippet: We report a case of recurrent cryptococcal meningitis in a pregnant woman living with vertically acquired HIV.. Despite effective treatment of primary infection prior to pregnancy, she later experienced a microbiological relapse of cryptococcal meningitis during pregnancy, and an immune-reconstitution inflammatory syndrome in the post-partum period.. This case emphasises the impact of pregnancy related immunological changes on the natural history of complex infections. Diffusion-based Assay:Article Title: Lipid Nanoparticle-Mediated Antifungal and Immunomodulatory Therapy for Neuromycoses Article Snippet: .. This pH-responsive property distinguishes ionizable LNPs from Activation Assay:Article Title: Role of Physicochemical Characteristics in Liposomal Doxorubicin: Effects on Pharmacokinetics and Biodistribution in Tumor-Bearing Mice Article Snippet: .. Szebeni J, Bedocs P, Rozsnyay Z, et al. Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Toxicity:Article Title: QbD-Driven Development of Angiopep-2 Modified PEGylated Liposomes for Enhanced Brain-Targeted Delivery of Amphotericin B: Formulation Optimization, Pharmacokinetics and Brain Distribution Article Snippet: 1 School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China 2 Anhui Provincial Key Laboratory of Drug Innovation and Advanced Pharmaceuticals, Hefei Industrial Pharmaceutical Institute Co., Ltd, Hefei 230088, China 3 School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China 4 School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China Abstract Purpose Amphotericin B (AmB) is the first-line agent for cryptococcal meningitis (CM).. However, its therapeutic efficacy is severely limited by poor blood-brain barrier (BBB) permeability, resulting in inadequate brain distribution even with commercial liposomal formulations.. The development of an active brain-targeted delivery system capable of receptor-mediated transcytosis (RMT) represents a promising strategy to overcome this limitation. Article Title: Therapeutic Drug Monitoring of Antifungal Agents: Toward Harmonization of Therapeutic Ranges Article Snippet: Background: Invasive fungal infections are associated with high morbidity and mortality, particularly among immunocompromised and critically ill patients.. Antifungal therapy is complicated by substantial pharmacokinetic variability, drug–drug interactions, and narrow therapeutic windows for some agents.. Although therapeutic drug monitoring (TDM) can optimize drug exposure, therapeutic targets vary across studies and guidelines. Article Title: Beyond Nanosizing: Mechanism-Guided Design and Rational Selection of Polymeric and Lipid Nanocarriers for Translatable Drug Delivery. Article Snippet: 1 CT University, Ludhiana, India 2 Smt.. Tarawati Institute of Biomedical and Allied Sciences, Roorkee, India 3 Raffles University, Neemrana, India 4 Surajmal University, Kichha, India 5 Bhai Gurdas Group of Institutions, Patiala, India Abstract Background Nanosizing can modify dissolution and carrier behaviour, but particle size alone does not determine clinically useful exposure.. Objective To compare polymeric and lipid-based nanocarriers using a mechanism-guided framework that links payload properties, composition, process conditions, biological barriers, critical quality attributes (CQAs), and translational risk. Preserving:Article Title: QbD-Driven Development of Angiopep-2 Modified PEGylated Liposomes for Enhanced Brain-Targeted Delivery of Amphotericin B: Formulation Optimization, Pharmacokinetics and Brain Distribution Article Snippet: 1 School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China 2 Anhui Provincial Key Laboratory of Drug Innovation and Advanced Pharmaceuticals, Hefei Industrial Pharmaceutical Institute Co., Ltd, Hefei 230088, China 3 School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China 4 School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China Abstract Purpose Amphotericin B (AmB) is the first-line agent for cryptococcal meningitis (CM).. However, its therapeutic efficacy is severely limited by poor blood-brain barrier (BBB) permeability, resulting in inadequate brain distribution even with commercial liposomal formulations.. The development of an active brain-targeted delivery system capable of receptor-mediated transcytosis (RMT) represents a promising strategy to overcome this limitation. |